References
- RennerBMuellerCAShephardAEnvironmental and non-infectious factors in the aetiology of pharyngitis (sore throat)Inflamm Res201261101041105222890476
- VincentMTCelestinNHussainANPharyngitisAm Fam Physician20046961465147015053411
- ESCMID Sore Throat Guideline GroupPelucchiCGrigoryanLGuideline for the management of acute sore throatClin Microbiol Infect201218Suppl 1128
- WorrallGJAcute sore throatCan Fam Physician200753111961196218000276
- SpinksAGlasziouPPDel MarCBAntibiotics for sore throatCochrane Database Syst Rev201311CD000023
- van DrielMLDe SutterADeveugeleMAre sore throat patients who hope for antibiotics actually asking for pain relief?Ann Fam Med20064649449917148626
- LinderJASingerDEDesire for antibiotics and antibiotic prescribing for adults with upper respiratory tract infectionsJ Gen Intern Med2003181079580114521641
- World Health OrganizationAntimicrobial Resistance Fact Sheet Available from: http://www.who.int/en/news-room/fact-sheets/detail/antimicrobial-resistance. Published February 15, 2018Accessed July 07, 2018
- DekkerARVerheijTJvan der VeldenAWInappropriate antibiotic prescription for respiratory tract indications: most prominent in adult patientsFam Pract201532440140725911505
- GullifordMCDreganAMooreMVContinued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practicesBMJ Open2014410e006245
- SheldonATJrAntiseptic “resistance”: real or perceived threat?Clin Infect Dis200540111650165615889364
- OxfordJSLambkinRGibbIBalasingamSChanCCatchpoleAA throat lozenge containing amyl meta cresol and dichlorobenzyl alcohol has a direct virucidal effect on respiratory syncytial virus, influenza A and SARS-CoVAntivir Chem Chemother200516212913415889535
- ShephardAZybeshariSVirucidal action of sore throat lozenges against respiratory viruses parainfluenza type 3 and cytomegalovirusAntiviral Res201512315816226408353
- FoadiNde OliveiraRCBuchholzVA combination of topical antiseptics for the treatment of sore throat blocks voltage-gated neuronal sodium channelsNaunyn Schmiedebergs Arch Pharmacol201438710991100025012093
- McNallyDSimpsonMMorrisCShephardAGoulderMRapid relief of acute sore throat with AMC/DCBA throat lozenges: randomised controlled trialInt J Clin Pract201064219420719849767
- WadeAGMorrisCShephardACrawfordGMGoulderMAA multicentre, randomised, double-blind, single-dose study assessing the efficacy of AMC/DCBA Warm lozenge or AMC/DCBA Cool lozenge in the relief of acute sore throatBMC Fam Pract2011121621332976
- ShephardASmithGAspleySSchachtelBPRandomised, double-blind, placebo-controlled studies on flurbiprofen 8.75 mg lozenges in patients with/without group A or C streptococcal throat infection, with an assessment of clinicians’ prediction of “strep throat”Int J Clin Pract2015691597125296661
- RadkovaEBurovaNBychkovaVDevitoREfficacy of flurbiprofen 8.75 mg delivered as a spray or lozenge in patients with sore throat due to upper respiratory tract infection: a randomized, non-inferiority trial in the Russian FederationJ Pain Res2017101591160028740426
- DagnelieCFTouw-OttenFWKuyvenhovenMMRozenberg-ArskaMRde MelkerRABacterial flora in patients presenting with sore throat in Dutch general practiceFam Pract19931043713778168671
- ShaikhNLeonardEMartinJMPrevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysisPediatrics20101263e557e56420696723
- BattyAWrenMWPrevalence of Fusobacterium necrophorum and other upper respiratory tract pathogens isolated from throat swabsBr J Biomed Sci2005622667015997879
- EatonCSwindellsJThe significance and epidemiology of Fusobacterium necrophorum in sore throatsJ Infect201469219419624642207
- HarringtonATClarridgeJE3rdImpact of identification of Streptococcus dysgalactiae subspecies equisimilis from throat cultures in an adult populationDiagn Microbiol Infect Dis2013761202323537788
- GergovaRTPetrovaGGergovSMinchevPMitovIStratevaTMicrobiological features of upper respiratory tract infections in Bulgarian children for the period 1998–2014Balkan Med J201633667568027994923
- LafontaineERWallDVanlerbergSLDonabedianHSledjeskiDDMoraxella catarrhalis coaggregates with Streptococcus pyogenes and modulates interactions of S. pyogenes with human epithelial cellsInfect Immun200472116689669315501804
- VerhaeghSJFloresARvan BelkumAMusserJMHaysJPDifferential virulence gene expression of group A Streptococcus serotype M3 in response to co-culture with Moraxella catarrhalisPLoS One201384e6254923626831
- MihanceaNFrequency and distribution per species, biotypes, resistance to antibiotics and beta-lactamase production of the hemophils isolated from patients with respiratory diseasesRoum Arch Microbiol Immunol199857212513711845430
- CarlsonPRenkonenOVKontiainenSArcanobacterium haemolyticum and streptococcal pharyngitisScand J Infect Dis19942632832877939427
- JensenAHansenTMBankSKristensenLHPragJFusobacterium necrophorum tonsillitis: an important cause of tonsillitis in adolescents and young adultsClin Microbiol Infect2015213266.e1e3
- KatkowskaMGarbaczKStromkowskiJStaphylococcus aureus isolated from tonsillectomized adult patients with recurrent tonsillitisAPMIS20171251465127862322
- ZautnerAEKrauseMStropahlGIntracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitisPLoS One201053e945220209109
- RichardsRMXingDKIn vitro evaluation of the antimicrobial activities of selected lozengesJ Pharm Sci19938212121812208308699
- CLSIMethods for Determining Bactericidal Activity of Antimicrobial Agents. Approved Guideline, CLSI Document M26-AWayne, PAClinical and Laboratory Standards Institute (CLSI)1999
- BuchholzVLeuwerMAhrensJFoadiNKrampflKHaeselerGTopical antiseptics for the treatment of sore throat block voltage-gated neuronal sodium channels in a local anaesthetic-like mannerNaunyn Schmiedebergs Arch Pharmacol2009380216116819367399